Introduction: Closely related plant species often share similar secondary metabolites and bioactivities and are therefore good targets for bioactivity testing when one or more species within a genus are known to possess therapeutic properties. The genus Piper has a long history of medicinal usage in many areas of the world. Many Piper spp. are known to have therapeutic properties and several have antibacterial bioactivities. Methods: The ability of P. novae-hollandiae leaf extracts to inhibit the growth of a panel of bacterial pathogens was investigated by disc diffusion assay. Toxicity was examined using the Artemia franciscana nauplii bioassay. Results: P. novae-hollandiae methanolic and aqueous extracts were completely ineffective at inhibiting the growth of panels of gram-positive and gram-negative bacteria. The extracts were nontoxic or of low toxicity to Artemia nauplii following 24 h exposure. Conclusion: Despite the close taxonomic relationship with several bioactive Piper spp. and its therapeutic use by first Australians, P. novae-hollandiae leaf extracts were completely ineffective bacterial growth inhibitors. However, these extracts may have other therapeutic properties and testing against protozoa, fungi, virus and tumour cells is warranted.
INTRODUCTION
The use of natural plant therapeutics is as old as human civilisation and in many regions of the world is still the primary modality of health care. Ayuverdic medicine in India for example is still commonly practiced, with approximately 85% of Indians using crude plant preparations for the treatment of various diseases and ailments. 1 Even in Western civilisations, plants play an important role in medicine. At least 25% of pharmaceuticals prescribed worldwide are directly obtained from plants and many more drugs are semi-synthetic derivatives of natural product precursors. [2] [3] [4] Examples of medicinally important plant derived compounds include the anti-malarial drugs quinine (from Cinchona spp.) and artemesinin (from Artemisia annua L.) and their derivatives; the anti-tumour drugs vincristine and vinblastine (from Catharanthus roseus (L.) G. Don), along with the semi-synthetic analogue vindesine; the analgesics morphine and codeine (from Papaver somniferum L.); the anticholinogenic drug atropine derived from plants of the family Solinaceae (Atropa belladonna L., Datura stramonium L. and Mandragora officinarum L.); the anticancer drug taxol (derived from Taxus brevifolia Nutt.); and the cardiac glycoside digoxin (from Digitalis purpurea L.). 5 Despite the potential of plants to provide us with useful pharmaceutical agents, the field is still relatively poorly studied. Only an estimated 5-10 % of the approximately 300, 000-500, 000 plant species worldwide have been screened for 1 or more bioactivities. 5 With so many plant species yet to be tested, it is essential that plant selection processes narrow the field. The main selection criteria currently used is to select plants on the basis of ethnobotanical usage as traditional medicines. Another important selection method is to examine plants closely related to species for which medicinal potential is well established. Many plant secondary metabolites are regarded as family, genus or species specific and investigation of species closely related to those used as traditional medicines may lead to natural therapeutic discovery of novel pharmaceuticals. 2 In recent years, the development of either extremely (XDR) or totally drug resistant (TDR) bacterial pathogens 6 has resulted in the need to develop new antibiotic chemotherapies. There are now limited therapeutic options for many diseases caused by bacteria and the situation is expected to worsen in the future as bacteria exchange resistance genes. Indeed, the development of alternative antibacterial treatment modalities has become crucial and is considered by the World Health Organisation (WHO) to be one of the most serious challenges currently facing medical science. 7 For a number of reasons reviewed elsewhere, 6 it is unlikely that the previous methods of antibiotic discovery/development will be as successful in the future and new treatment modalities are urgently required. Traditional medicines and herbal remedies have great potential for antimicrobial drug development and there has recently been a substantial increase in interest in this field. 8, 9 The genus Piper (Family Piperaceae) consists of approximately 1000 species, many with global distribution. 10 Many Piper spp. are used as spices for their pleasant flavour characteristics, with Piper nigrum L. (black pepper) being the best known for this purpose. The raw unripe P. nigrum fruit yields green pepper, the unripe cooked fruit gives black pepper, whilst the ripe fruit is used as white pepper. Several Piper spp. also have long histories of medicinal use in the treatment of a wide variety of medical disorders and conditions. The genus Piper may be particularly useful as antibacterial therapies. Indeed, the use of Piper spp. extracts in ancient Asian ethnopharmacological practices has been well documented and P. nigrum is a component of many traditional medicines still commonly in use. 10 Piper guineense Schumach. has similar therapeutic uses. Substantially less information is known about the Australian species Piper novae-hollandiae Miq., although its medicinal uses by the first Australians have been recorded. 11, 12 Whilst it is mainly known for its tonic properties, it was also used in the treatment of some bacterial diseases, including STIs. Figure 1c ). There is a lack of information on the phytochemical composition of this species. However, the phytochemistry of other species has been reported 13 and is characterised by relatively high levels of mono-and sesquiterpenoids, including piperitone, (Figure 1d Figure  1j ). Many of these have been reported to have potent antibacterial activity 14 and may therefore contribute to the antibacterial properties of other Piper spp. This study was undertaken to screen of P. novae-hollandiae leaf extracts for the ability to inhibit the growth of a panel of gram-positive and gram-negative bacterial pathogens.
MATERIALS AND METHODS

Collection of Plant Material and Extraction
Piper novae-hollandiae Miq. Leaves were harvested from wild plants in Toohey Forest Australia, washed in deionised water and processed within 4 hrs of collection. The leaves were dried in a Sunbeam food dehydrator and the dried material was ground to a coarse powder. Individual 1g masses of the dried plant material was extracted extensively in 50mL methanol (Ajax, AR grade) or deionised water for 24 hrs at 4 o C with gentle shaking. The extract was filtered through filter paper (Whatman No. 54) under vacuum followed by drying by rotary evaporation. The resultant pellet was dissolved in 5mL deionised water. The extract was passed through 0.22µm filter (Sarstedt) and stored at 4 o C.
Qualitative Phytochemical Studies
Phytochemical analysis of the P. novae-hollandiae leaf extracts for the presence of saponins, phenolic compounds, flavonoids, phytosteroids, triterpenoids, cardiac glycosides, anthraquinones, tannins and alkaloids was conducted by standard assays. [15] [16] [17] Antibacterial Screening
Test Microorganisms
All media was purchased from Oxoid Ltd., Australia. 
Evaluation of Antimicrobial Activity
Antimicrobial activity of the P. novae-hollandiae leaf extracts was determined using a modified disc diffusion assay. [18] [19] [20] Briefly, 100µL of the each bacterial suspension in log phase was spread onto individual nutrient agar plates and the extracts were tested for antibacterial activity using 6mm sterilised filter paper discs. The discs were each infused with 10µL of the individual plant extract, allowed to dry and placed onto the inoculated plates. The plates were allowed to stand at 4°C for 2h before incubation at 37°C for 24h. The diameters of the zones of inhibition (ZOIs) were measured to the closest whole millimetre. Each assay was performed three times in triplicate (n=9). Mean values (± SEM) are reported in this study. Standard discs of ampicillin (10µg) and chloramphenicol (10µg) were obtained from Oxoid, Australia and were used as positive controls to compare antibacterial activity. Filter discs infused with 10µL of distilled water were used as a negative control.
Artemia franciscana Nauplii Toxicity Screening
Toxicity was tested using an adapted Artemia franciscana nauplii lethality assay. [21] [22] [23] Briefly, A. franciscana nauplii were incubated in the presence of the extracts, reference toxin (1mg/mL potassium dichromate) or artificial seawater (negative control) at 25±1 o C under artificial light. All treatments were performed three times in triplicate (n=9). The number of dead were counted in each well at 24h and 48h. At the completion of the 48h exposure period, the remaining live nauplii were sacrificed and the total number of nauplii in each well were counted and used to calculate the percentage mortality per well. LC 50 values were calculated for each treatment using probit analysis.
Statistical Analysis
Data are expressed as the mean ± SEM of three independent experiments with internal triplicates (n=9). One-way ANOVA was used to calculate statistical significance between control and treated groups, with a P value < 0.01 considered to be statistically significant.
RESULTS
Liquid Extraction Yields and Qualitative Phytochemical Screening
Extraction of 1g of dried and powdered P. novae-hollandiae leaves with methanol and water yielded 296 and 265mg of extracted material respectively ( Table 1) . The extracts were resuspended in 10mL of deionised water (containing 1% DMSO), resulting in an extract concentration shown in Table 1 . Qualitative phytochemical studies showed that both extracts had similar phytochemical profiles. Both contained high levels of phenolic compounds and flavonoids. Lower levels of saponins, triterpenoids and tannins were also detected. Cardiac glycosides, phytosterols, alkaloids and anthraquinones were completely absent or below the detection thresholds for these assays.
Antibacterial Activity
To determine the growth inhibitory activity of the P. novae-hollandiae leaf extracts, aliquots (10µL) of each extract were screened in the disc diffusion assay. The P. novae-hollandiae leaf extracts were ineffective at inhibiting the growth of all gram-negative ( Figure 2 ) and gram-positive ( Figure 3 ) bacterial species tested. In contrast, both positive control antibiotics (ampicillin and chloramphenicol) were effective growth inhibitors, with ZOI's of up to 14.3mm (chloramphenicol against E. coli). We were therefore unable to determine MIC values for the extracts against any bacteria as they were completely ineffective at all concentrations tested.
Quantification of Toxicity
The toxicity of the P. novae-hollandiae leaf extracts was initially tested at 2mg/mL in the A. franciscana nauplii bioassay (Figure 4) . The mortality in the presence of all extracts was not significantly different to that of the untreated control at 24h and thus were deemed to be non-toxic. Extracts with 24h LC 50 values >1000µg/mL have previously been defined as non-toxic. 23 In contrast, the potassium dichromate positive control induced substantial mortality within 4h (results not shown), with 100% mortality induction seen by 24h. The mortality increased following exposure to the P. novae-hollandiae leaf extracts at 48h and was further increased following 72h exposure.
DISCUSSION
Due to recent increases in bacterial resistance to many antibiotics, the development of new antibiotic chemotherapies is a high priority for medical science. 6, 7 A concurrent decrease in the discovery of new antibiotic medicines by conventional strategies has increased interest in re-evaluating medicinal plants for new antibiotic chemotherapies.
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P. novae-hollandiae was used by the first Australians to treat a number of diseases, some of which are caused by bacterial pathogens. Furthermore, as P. novae-hollandiae is taxonomically related to other species including P. nigrum and P. guineense that have antibacterial activity, it was deemed a viable target for antibacterial screening. Surprisingly, the P. novaehollandiae extracts were completely inactive against all gram-positive and gram-negative bacteria tested.
It is noteworthy that a single assay technique was used to screen for antibacterial activity in this study. We chose to use the disc diffusion assay as it is a rapid methodology and it has previously been widely utilised in other studies. Therefore, comparisons between studies are relatively simple. However, as the disc diffusion method is reliant on the diffusion of a molecule through the aqueous environment of an agar gel, this assay may be affected by the solubility of the extract compounds in the aqueous environment. Polar compounds that are highly soluble in water would be expected to diffuse easily in the gel, whereas less soluble compounds would not diffuse as readily and thus be concentrated around the disc. For this reason, whilst this is a handy assay for screening aqueous extracts, this technique may not be ideal for nonpolar compounds (e.g. when screening essential oil and their components). For examining nonpolar mixtures, other techniques such as liquid dilution assays may be preferred. As Piper spp. are known to contain relatively high levels of nonpolar terpenoid components, their activity may have been significantly under estimated in our study. Liquid dilution studies may have been better suited to screen the P. novae-hollandiae for activity and future studies will use these techniques to re-examine the extracts for antibacterial activity. Diffusion of molecules within an agar gel is also affected by the size of the molecules. The movement of large, complex phytochemicals (e.g. complex tannins) through agar gels by diffusion would also be hampered and may provide a false idea of the efficacy of an extract. As many tannins have well described antibiotic properties, screening for growth inhibition using agar diffusion techniques may have given a distorted view of the inhibitory potential of the extracts. The findings reported here also indicate that the extracts examined were non-toxic (24h LC 50 >1000µg/mL) in the Artemia nauplii bioassay. Whilst toxicity was assessed in this study with the test organism A. franciscana, toxicity towards A. franciscana has previously been shown to correlate well with toxicity towards human cells for many toxins. 23 However, further studies are required to determine whether this is also true for the P. novae-hollandiae leaf extracts examined in these studies.
CONCLUSION
Methanolic and aqueous P. novae-hollandiae leaf extracts displayed no antibacterial activity in the disc diffusion assay against a panel of human pathogenic bacteria, despite their close taxonomic relationship with other Piper spp. with well known antibacterial properties. The extracts were non-toxic towards Artemia nauplii. 
